Iontophoretic delivery of a telomeric oligonucleotide

被引:37
作者
Brand, RM [1 ]
Iversen, PL [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PHARMACOL,OMAHA,NE 68198
关键词
iontophoresis; transdermal drug delivery; oligonucleotides; telomerase; hairless mouse skin;
D O I
10.1023/A:1016092809914
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To evaluate the feasibility of iontophoretically enhanced transdermal delivery of a phosphorothioate oligonucleotide across hairless mouse skin. Methods. The phosphorothioate sequence, 5'-d(TTAGGG)-3' (TAG6) which mimics the repeat sequence of the telomere was used as a model compound. Iontophoresis was performed on hairless mouse skin using an in vitro flow-through diffusion system. Both 5'-FITC and uniformly S-35 labeled oligonucleotide were used to monitor transdermal flux. Results. Cathodal delivery of TAG-6 resulted in substantial oligonucleotide flux. The molecular label did not alter transport properties. No flux was measured with either anodal or passive delivery. The oligonucleotide was not degraded as it crossed the skin. Molecular transport was donor condition dependent, with pH and salt concentration both having significant effects. Pre-treating the skin with ethanol reduced iontophoretic transport. Conclusions. These data demonstrate that iontophoresis can enhance transdermal flux of an intact phosphorothioate oligonucleotide and that this penetration is donor condition dependent. Furthermore, iontophoretically enhanced transdermal delivery is a feasible apprach to the administration of phosphorothioate oligonucleotides.
引用
收藏
页码:851 / 854
页数:4
相关论文
共 21 条
  • [1] REACTION BETWEEN METABOLICALLY ACTIVATED ACETAMINOPHEN AND PHOSPHOROTHIOATE OLIGONUCLEOTIDES
    COPPLE, BL
    GMEINER, WM
    IVERSEN, PL
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (01) : 53 - 63
  • [2] TELOMERASE ACTIVITY IN HUMAN OVARIAN-CARCINOMA
    COUNTER, CM
    HIRTE, HW
    BACCHETTI, S
    HARLEY, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 2900 - 2904
  • [3] PENETRATION ENHANCEMENT FOR POLYPEPTIDES THROUGH EPITHELIA .D. ROUTES OF DELIVERY - CASE-STUDIES .6. TRANSDERMAL DELIVERY OF PEPTIDES AND PROTEINS
    CULLANDER, C
    GUY, RH
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1992, 8 (2-3) : 291 - 329
  • [4] THE RNA COMPONENT OF HUMAN TELOMERASE
    FENG, JL
    FUNK, WD
    WANG, SS
    WEINRICH, SL
    AVILION, AA
    CHIU, CP
    ADAMS, RR
    CHANG, E
    ALLSOPP, RC
    YU, JH
    LE, SY
    WEST, MD
    HARLEY, CB
    ANDREWS, WH
    GREIDER, CW
    VILLEPONTEAU, B
    [J]. SCIENCE, 1995, 269 (5228) : 1236 - 1241
  • [5] A NEW SYSTEM FOR INVITRO STUDIES OF IONTOPHORESIS
    GLIKFELD, P
    CULLANDER, C
    HINZ, RS
    GUY, RH
    [J]. PHARMACEUTICAL RESEARCH, 1988, 5 (07) : 443 - 446
  • [6] OPTIMIZATION OF IONTOPHORETIC TRANSDERMAL DELIVERY OF A PEPTIDE AND A NONPEPTIDE DRUG
    GUPTA, SK
    KUMAR, S
    BOLTON, S
    BEHL, CR
    MALICK, AW
    [J]. JOURNAL OF CONTROLLED RELEASE, 1994, 30 (03) : 253 - 261
  • [7] SKIN BIOLOGICAL ISSUES IN ELECTRICALLY ENHANCED TRANSDERMAL DELIVERY
    LEDGER, PW
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1992, 9 (2-3) : 289 - 307
  • [8] LIEB LM, 1995, P INT S CONT REL BIO, V22, P654
  • [9] NAGEL KM, 1993, PHARMACOTHERAPY, V13, P177
  • [10] OLSENBURG KR, 1995, J PHARM SCI, V84, P915